Alcohol abuse and liver enzymes (AALE): results of an intercompany study of mortality.
Evaluation of applicants for life insurance who have elevations of their liver function tests or an increased probability of alcohol abuse has always been difficult for underwriters. This paper reports the results of an intercompany study in which the pooled mortality experience of a group of insureds with evidence of alcohol abuse, an adverse driving record or elevations of the liver transaminases or gamma-glutamyl transferase is summarized.
Titcomb
C
C
cptitcomb@lnc.com
Braun
R
R
Roudebush
B
B
Mast
J
J
Woodman
H
H
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000201:enzymology / Q000401:mortality; D001219:Aspartate Aminotransferases / Q000097:blood; D001334:Automobile Driving; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D007352:Insurance, Life; D008107:Liver Diseases / Q000201:enzymology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D011795:Surveys and Questionnaires; D005723:gamma-Glutamyltransferase / Q000097:blood
D015415:Biomarkers; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases